Chi Advisors LLC G1 Therapeutics, Inc. Transaction History

Chi Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$5.19 - $13.5 $51,900 - $135,000	10,000 Added 3.09%	333,945 $1.81 Million
Q3 2022 Nov 09, 2022	SELL	$5.17 - $16.99 $2.29 Million - $7.53 Million	-443,290 Reduced 57.78%	323,945 $4.05 Million
Q2 2022 Aug 12, 2022	BUY	$4.04 - $8.51 $1.13 Million - $2.37 Million	278,600 Added 57.02%	767,235 $3.79 Million
Q1 2022 May 16, 2022	BUY	$7.6 - $11.02 $1.97 Million - $2.85 Million	258,635 Added 112.45%	488,635 $3.71 Million
Q4 2021 Feb 11, 2022	BUY	$10.16 - $16.17 $1.83 Million - $2.91 Million	180,000 Added 360.0%	230,000 $2.35 Million
Q1 2021 May 14, 2021	SELL	$17.58 - $32.59 $210,959 - $391,080	-12,000 Reduced 19.35%	50,000 $1.2 Million
Q4 2020 Feb 12, 2021	SELL	$10.99 - $20.4 $241,780 - $448,799	-22,000 Reduced 26.19%	62,000 $1.12 Million
Q3 2020 Nov 12, 2020	BUY	$11.55 - $23.75 $462,000 - $950,000	40,000 Added 90.91%	84,000 $970,000
Q2 2020 Aug 12, 2020	BUY	$9.57 - $24.37 $421,080 - $1.07 Million	44,000 New	44,000 $1.07 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Chi Advisors LLC with notifications on news.